IQVIA Middle East and Africa

In the dynamic #pharma landscape, companies operating in emerging markets face significant challenges, including increasing production costs, decreasing net profits, and rising labor and distribution expenses. To empower life sciences companies to navigate the evolving economic environment we have outlined 7 key trends in commercial productivity and cost optimization. When implemented successfully, these solutions, along with AI/ML tools that unlock data-driven decision making, enhanced forecasting, and personalized marketing, can boost performance, efficiency and profitability. Reach out to our experts to learn more: https://lnkd.in/dZg7yuSy

Did you know that 30% of the world’s data volume is clinical data? Emerging technologies like IoT and 5G are transforming healthcare. The global wearable #healthcare market was valued at USD 42.7 billion in 2024 and is projected to grow at a CAGR of 25.5% from 2025 to 2030. Managing and sharing this information effectively across diverse organizations is a pivotal challenge. To address this, we need healthcare systems that are semantically and structurally cohesive, enabling seamless data exchange. This requires formal data descriptions, standardized vocabularies, and machine-readable formats. #Interoperability is the linchpin of the #digitalhealth revolution, providing a basis for efficient communication, data curation, and the secondary use of real-world data in medical science — essential for well-informed decision-making. Reach out to our experts to learn more about how we can help your organization achieve seamless data interoperability: https://lnkd.in/d43GmRmz Source: https://lnkd.in/e_qZRm5g

IQVIA offers a place for personal and professional growth. "Working at IQVIA has enhanced my teamwork abilities and sharpened my leadership skills," Senior Health Economics and Outcomes Research (HEOR) Consultant Mai Alsaqa'aby explains. "The opportunities provided have allowed me to grow faster and reach a wide range of audiences interested in the HEOR field." "IQVIA offers a flexible and friendly work environment, which I have found to be very supportive and conducive to productivity," she added. As for why she chose to work in the field of HEOR, "HEOR has been my passion since college. I chose this field because it allows me to raise awareness and do what I love, providing a platform to make a meaningful impact." Looking for opportunities where you can grow your career and make an impact? Visit jobs.iqvia.com to learn more.

Clinical trials often face challenges, especially when uncontrolled trials are conducted for rare or serious drug indications. These trials, lacking a concurrent control arm, can introduce bias. To mitigate this, sponsors use external controls like Synthetic Control Arms (SCAs), which utilize patient-level data from external sources. SCAs have become a valuable tool in #clinicalresearch, offering an alternative to traditional control groups, reducing costs, and speeding up trial results. Read our latest white paper to learn more about the principles, benefits, and challenges of SCAs, particularly in real-world evidence studies: https://bit.ly/4hJ7T8D Rula Sakhr Dr.Akash M. Dr. Irfan A.

Join IQVIA experts from Africa, the Middle East, and South Asia as they share key insights on the consumer health market for 2025. Join us on February 25 as Tina Khadloya, Jo-Anne Grebe, Amine Mansouri, Adhiti Kumar, Ashraf Bahaa, and Rubina Farooqui talk about the trends in the market to look out for including: ✅ Key developments in the OTC markets ✅ The growing ageing population ✅ The dynamic channel play ✅ The rise of claim generation Don’t miss out on this valuable discussion. Register now! https://lnkd.in/dvR2MUdR #consumerhealth #middleeast #Africa #India #markettrends

This year, real-world evidence is emerging as a game-changer in healthcare. This blog by IQVIA's Katarzyna Grzeslak examines how RWE is transforming the industry. Read the blog to learn how RWE will change healthcare in 2025, from its potential in manufacturing and patient care to expected changes in regulations: https://lnkd.in/dJEzyhHG Don't miss our upcoming webinar for more insights on 2025 RWE trends: https://lnkd.in/dc_GWxY7 #Healthcare #RWE #PatientCare #realworldevidence

On Friday, Naim Hage, PhD, Cluster Head at IQVIA Middle Africa, participated in a panel discussion at the 4th Annual #NCD (#Noncommunicablediseases) Alliance Forum in Kigali, Rwanda. The panel focused on "Improving Interconnected Cardiovascular, Renal & Metabolic Health in #Africa and Beyond." Naim, along with other industry experts, leaders, and stakeholders, shared valuable insights on: ✅ The importance of addressing interconnected cardiovascular, renal, and metabolic diseases in NCD strategies to achieve NCD targets. ✅ Key actions needed ahead of the upcoming UN High-level meeting on NCDs to advance interconnected cardiovascular, renal, and metabolic health for all. ✅ Lessons learned from successful initiatives addressing cardiovascular, renal, and metabolic diseases at the regional level, across Africa and beyond.

IQVIA has been named a ‘Front-runner’, the highest ranking, in Everest Group’s 'AI-deas to Action: Operationalizing Generative AI in Life Sciences’, which evaluated 15 providers for their ability to provide #GenerativeAI solutions to the industry. Learn more: https://bit.ly/42VGPOZ

IQVIA is proud to announce that a recent study our very own Engagement Manager Harmandeep Singh took part in has been published in the Open Respiratory Medicine Journal! The study highlights the transformative potential of rapid molecular point-of-care (POC) tests for respiratory infections in the UAE, an innovative approach that promises to revolutionize diagnostic practices, reduce healthcare resource consumption, and significantly improve patient outcomes.  Read the article to learn about the potential rapid molecular POC tests have to offer: https://lnkd.in/d9ZtGBPx #HealthcareInnovation #RespiratoryMedicine #POCTesting #PrecisionMedicine

Portfolio differentiation and diversification are key to growing sustainably in MENA. Local and regional #LifeScience firms in MENA are facing barriers to sustainable growth due to lack of a quality portfolio. These challenges manifest across the value chain and cost millions of dollars to the healthcare economy, including lower access to specialty, life-saving drugs, supply security concerns, high import prices, and lower profitability. Considering this, #portfolio-driven BD, including in-licensing, JVs, and M&A deals, offers a viable option. By acquiring commercial rights or technology from a specialty developer or strategic partner globally, firms can avoid long market lead times and heavy capex of traditional approaches. Deals can cover not only complex formulations or devices but also, crucial APIs for MENA #localization, or R&D with CDMOs. Reach out to our experts to learn how you can explore these opportunities and leverage BD deals to stand out: https://bit.ly/4gzy8gB